A Practical Scheme for the Initial Out-Patient Management of Type-2 Diabetes Mellitus

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–97.

World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1 Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO Department of Non-communicable Disease Surveillance, 1999.

World Health Organization. Diabetes Mellitus: Report of a WHO Study Group, Technical Report Series 727. Geneva: WHO, 1985.

Amos AF McCarty DJ Zimmet P . The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabetic Med 1917; 14 (suppl 5): S1–85.

UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.

UK Prospective Diabetes Study Group. Tight blood pressure control and the risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998; 317: 703–13.

Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.

Groop LC. Sulfonylureas in NIDDM. Diabetes Care 1992; 15: 737–54.

DeFronzo RA Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus: The Multicenter Metformin Study Group. N Engl J Med 1995; 333: 541–9.

Ilkova H Glaser B Tunckale A Bagriacik N Cerasi E . Induction of longterm glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetic Care 1997; 20: 1353–6.

Kayashima T Yamaguchi K Konno Y Nanimastu H Aragaki S Schichiri M . Effects of early introduction of intensive insulin therapy on the clinical course in non-obese NIDDM patients. Diabetes Res Clin Pract 1995; 28: 119–25.

DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999; 131: 281–303.